Synchroneuron Inc.
Records under this name other than the patents Synchroneuron Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 10 of 10 · Back to Synchroneuron Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,117,877 | Method for treating painful conditions of the anal region and compositions therefor Term ended Term ended Feb 25, 2019 · From the USPTO record | Term ended | Term ended Feb 25, 2019 | From the USPTO record |
| US 6,057,373 | Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists Term ended Term ended Jan 4, 2019 · From the USPTO record | Term ended | Term ended Jan 4, 2019 | From the USPTO record |
| US 6,294,583 | Methods of treating tardive dyskinesia and other movement disorders Term ended Term ended Nov 18, 2018 · From the USPTO record | Term ended | Term ended Nov 18, 2018 | From the USPTO record |
| US 6,689,816 | Treatment of Posttraumatic Strees Disorder, Obsessive-Compulsive Disorder and Related Neuropsychiatric Disorders Term ended Ended no later than Feb 24, 2018 · Low confidence | Term ended | Ended no later than Feb 24, 2018 | Low confidence |
| US 6,391,922 | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders Term ended Term ended Jan 13, 2018 · From the USPTO record | Term ended | Term ended Jan 13, 2018 | From the USPTO record |
| US 7,498,361 | Methods of Treating Tardive Dyskinesia and Other Movement Disorders Term ended Ended no later than Jan 13, 2018 · Low confidence | Term ended | Ended no later than Jan 13, 2018 | Low confidence |
| US 7,745,493 | Methods of Treating Tardive Dyskinesia and Other Movement Disorders Term ended Term ended Jan 13, 2018 · Medium confidence | Term ended | Term ended Jan 13, 2018 | Medium confidence |
| US 6,159,944 | Method for treating painful conditions of the anal region and compositions therefor Lapsed on the fee record Ended Dec 12, 2012 · From the USPTO record | Lapsed on the fee record | Ended Dec 12, 2012 | From the USPTO record |
| US 5,866,585 | Methods of treating tardive dyskinesia using NMDA receptor antagonists Term ended Term ended no later than Feb 2, 2019 · Low confidence | Term ended | Term ended no later than Feb 2, 2019 | Low confidence |
| US 5,952,389 | Methods of treating tardive dyskinesia and other movement disorders Term ended Term ended no later than Sep 14, 2019 · Low confidence | Term ended | Term ended no later than Sep 14, 2019 | Low confidence |